Hyaluronic acid prodrug micelles for tumour therapy

J Drug Target. 2022 Jan;30(1):22-30. doi: 10.1080/1061186X.2021.1919125. Epub 2021 Oct 14.

Abstract

Hyaluronic acid (HA), an important component of the extracellular matrix, has high water solubility and biocompatibility, and good application prospects in biomedicine. Especially in tumour treatment, prodrug polymer micelles prepared from HA and chemotherapeutics can increase water solubility, prolong drug release time, improve organ distribution and therapeutic effects, and show good tumour targeting and biocompatibility. Therefore, this study introduces strategies for using HA to prepare prodrug polymer micelles and discusses recent research on HA prodrug micelles for antitumor applications.

Keywords: Hyaluronic acid; antitumor; micelle; prodrug; tumour therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Liberation
  • Humans
  • Hyaluronic Acid
  • Micelles
  • Neoplasms* / drug therapy
  • Neoplasms* / pathology
  • Prodrugs* / therapeutic use

Substances

  • Micelles
  • Prodrugs
  • Hyaluronic Acid